Terug
Dagbereik
€ 55,05
€ 57,12
52-Weeksbereik
€ 27,66
€ 75,33
Volume
1.024.037
50D / 200D Gem.
€ 54,82
/
€ 42,62
Vorige Slotkoers
€ 54,72
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,5 | 0,4 |
| P/B | 3,0 | 2,9 |
| ROE % | -25,6 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 83,00
+48.4%
Low: € 77,00
High: € 89,00
Forward WPA
-€ 7,18
Omzet Sch.
25 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 6,17
€ 6,17 – € 6,17
|
2,3 B | 2 |
| FY2029 |
€ 1,14
€ 1,14 – € 1,14
|
1,4 B | 4 |
| FY2028 |
-€ 5,95
-€ 9,82 – -€ 4,39
|
290 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,09 — conservative balance sheet
Negative free cash flow of -669,29M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-25,59%
ROIC-23,77%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,09
Current Ratio7,91
Interest Coverage0,00
Waardering
P/E Ratio
-10,50
P/B Ratio3,00
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -766,63M |
| ROE | -25,59% | ROA | -25,17% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -669,29M |
| ROIC | -23,77% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 7,91 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,50 | P/B Ratio | 3,00 |
| P/S Ratio | N/A | PEG Ratio | -0,17 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 8,05B | Enterprise Value | 8,11B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -766,63M | -463,93M | -402,27M | -223,49M | -100,08M |
| EPS (Diluted) | -5,63 | -3,80 | -4,14 | -3,44 | -1,93 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -923,68M | -569,55M | -468,04M | -232,26M | -103,67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,05B | 3,51B | 1,41B | 1,01B | 324,34M |
| Total Liabilities | 360,46M | 205,50M | 167,45M | 52,57M | 40,32M |
| Shareholders' Equity | 2,69B | 3,31B | 1,24B | 953,61M | 284,02M |
| Total Debt | 228,84M | 71,11M | 29,22M | 17,94M | 16,78M |
| Cash & Equivalents | 173,96M | 387,88M | 397,45M | 834,66M | 68,99M |
| Current Assets | 1,63B | 1,79B | 1,10B | 942,56M | 256,35M |
| Current Liabilities | 205,75M | 140,18M | 145,34M | 40,53M | 28,72M |